Final answer:
In systemic lupus erythematosus (SLE), antibodies to double-stranded DNA are unique to the disease, signifying a high specificity to SLE. Antinuclear antibodies indicate the patient's immune system is attacking their own nuclear material.
Step-by-step explanation:
In patients with a new onset of systemic lupus erythematosus (SLE), the unique autoantibody test result that is highly specific to SLE is the presence of antibodies to double-stranded DNA (ds-DNA). These autoantibodies are part of the classification criteria for SLE because they are not generally found in other diseases.
The significance of the presence of antinuclear antibodies (ANAs) in SLE is that they indicate the patient's immune system is creating antibodies that incorrectly target the individual's own nuclear material, such as DNA and proteins.